The current valuation score of Allarity Therapeutics Inc is 8.48, ranking 95 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.71, which is -120.04% below the recent high of 0.34 and -40.50% above the recent low of -2.40.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.